相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
Zhao Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Novel RNase H Inhibitors Blocking RNA-directed Strand Displacement DNA Synthesis by HIV-1 Reverse Transcriptase
Samara Martin-Alonso et al.
JOURNAL OF MOLECULAR BIOLOGY (2022)
Avoiding Drug Resistance in HIV Reverse Transcriptase
Maria E. Cilento et al.
CHEMICAL REVIEWS (2021)
Structural insights into understudied human cytochrome P450 enzymes
David Machalz et al.
DRUG DISCOVERY TODAY (2021)
Advances toward Curing HIV-1 Infection in Tissue Reservoirs
Lisa J. Henderson et al.
JOURNAL OF VIROLOGY (2020)
Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years
Chunlin Zhuang et al.
ACTA PHARMACEUTICA SINICA B (2020)
The New NNRTI ACC007 Combined with Lamivudine and Tenofovir Disoproxil Fumarate Show Synergy Anti-HIV Activity In Vitro
Xu-Sheng Huang et al.
CURRENT HIV RESEARCH (2020)
Design, synthesis and anti-HIV evaluation of 5-alkyl-6-(benzo[d][1,3] dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs
Yi-Ming Li et al.
BIOORGANIC CHEMISTRY (2020)
Four Decades of HIV/AIDS - Much Accomplished, Much to Do
Anthony S. Fauci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comparative Circulation Dynamics of the Five Main HIV Types in China
Bram Vrancken et al.
JOURNAL OF VIROLOGY (2020)
Recent discoveries in HIV-1 reverse transcriptase inhibitors
Shuang-Xi Gu et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens
Murugesan Vanangamudi et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Recent Advances in the Design and Development of Non-nucleoside Reverse Transcriptase Inhibitor Scaffolds
Pouria Shirvani et al.
CHEMMEDCHEM (2019)
Challenges and approaches in the discovery of human immunodeficiency virus type-1 non-nucleoside reverse transcriptase inhibitors
Leandro Battini et al.
MEDICINAL RESEARCH REVIEWS (2019)
Elsulfavirine: First Global Approval
Zaina T. Al-Salama
DRUGS (2017)
Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles
Dongwei Kang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse-transcriptase inhibitor KM-023 in healthy subjects
Yu-Jung Cha et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
DB-02, a C-6-Cyclohexylmethyl Substituted Pyrimidinone HIV-1 Reverse Transcriptase Inhibitor with Nanomolar Activity, Displays an Improved Sensitivity against K103N or Y181C Than S-DABOs
Xing-Jie Zhang et al.
PLOS ONE (2013)
In-Depth Characterization of Viral Isolates from Plasma and Cells Compared with Plasma Circulating Quasispecies in Early HIV-1 Infection
Judith Dalmau et al.
PLOS ONE (2012)
Differential restoration of myeloid and plasmacytoid dendritic cells in HIV-1-infected children after treatment with highly active Antiretroviral therapy
Zheng Zhang et al.
JOURNAL OF IMMUNOLOGY (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)